Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 16
1957 33
1958 9
1959 5
1965 6
1966 9
1967 11
1968 3
1969 7
1970 9
1971 8
1972 13
1973 11
1974 17
1975 21
1976 25
1977 27
1978 36
1979 27
1980 67
1981 59
1982 53
1983 61
1984 53
1985 39
1986 45
1987 50
1988 28
1989 38
1990 25
1991 36
1992 29
1993 36
1994 23
1995 25
1996 24
1997 25
1998 23
1999 10
2000 10
2001 11
2002 11
2003 16
2004 19
2005 43
2006 27
2007 30
2008 28
2009 30
2010 24
2011 44
2012 29
2013 29
2014 43
2015 50
2016 66
2017 67
2018 75
2019 81
2020 88
2021 76
2022 14
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

1,867 results

Results by year

Filters applied: . Clear all
Page 1
Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.
Fong PC, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M, Mortimer P, Swaisland H, Lau A, O'Connor MJ, Ashworth A, Carmichael J, Kaye SB, Schellens JH, de Bono JS. Fong PC, et al. N Engl J Med. 2009 Jul 9;361(2):123-34. doi: 10.1056/NEJMoa0900212. Epub 2009 Jun 24. N Engl J Med. 2009. PMID: 19553641 Free article. Clinical Trial.
Olaparib.
Goulooze SC, Cohen AF, Rissmann R. Goulooze SC, et al. Br J Clin Pharmacol. 2016 Jan;81(1):171-3. doi: 10.1111/bcp.12761. Epub 2015 Oct 24. Br J Clin Pharmacol. 2016. PMID: 26344419 Free PMC article.
Parenteral hydralazine revisited.
Powers DR, Papadakos PJ, Wallin JD. Powers DR, et al. J Emerg Med. 1998 Mar-Apr;16(2):191-6. doi: 10.1016/S0736-4679(97)00287-4. J Emerg Med. 1998. PMID: 9543400 Free article. Review.
Olaparib for the treatment of breast cancer.
Griguolo G, Dieci MV, Guarneri V, Conte P. Griguolo G, et al. Expert Rev Anticancer Ther. 2018 Jun;18(6):519-530. doi: 10.1080/14737140.2018.1458613. Epub 2018 Mar 30. Expert Rev Anticancer Ther. 2018. PMID: 29582690 Review.
Talazoparib to treat BRCA-positive breast cancer.
Guney Eskiler G. Guney Eskiler G. Drugs Today (Barc). 2019 Jul;55(7):459-467. doi: 10.1358/dot.2019.55.7.3015642. Drugs Today (Barc). 2019. PMID: 31347614 Review.
Olaparib for the treatment of breast cancer.
Robert M, Frenel JS, Gourmelon C, Patsouris A, Augereau P, Campone M. Robert M, et al. Expert Opin Investig Drugs. 2017 Jun;26(6):751-759. doi: 10.1080/13543784.2017.1318847. Epub 2017 Apr 21. Expert Opin Investig Drugs. 2017. PMID: 28395540 Review.
Hypertensive emergencies of pregnancy.
Alexander JM, Wilson KL. Alexander JM, et al. Obstet Gynecol Clin North Am. 2013 Mar;40(1):89-101. doi: 10.1016/j.ogc.2012.11.008. Obstet Gynecol Clin North Am. 2013. PMID: 23466139 Review.
Hydralazine for essential hypertension.
Kandler MR, Mah GT, Tejani AM, Stabler SN, Salzwedel DM. Kandler MR, et al. Cochrane Database Syst Rev. 2011 Nov 9;(11):CD004934. doi: 10.1002/14651858.CD004934.pub4. Cochrane Database Syst Rev. 2011. PMID: 22071816 Review.
Hydralazine for essential hypertension.
Kandler MR, Mah GT, Tejani AM, Stabler SN. Kandler MR, et al. Cochrane Database Syst Rev. 2010 Aug 4;(8):CD004934. doi: 10.1002/14651858.CD004934.pub3. Cochrane Database Syst Rev. 2010. PMID: 20687078 Updated. Review.
HYDRALLAZINE.
[No authors listed] [No authors listed] Lancet. 1977 Feb 12;1(8007):342-3. Lancet. 1977. PMID: 64864 No abstract available.
1,867 results